This series on "Evidence of Epigenetics in Inflammatory Bowel Diseases" is edited by Dr. Patrick Varga-Weisz, University of Essex, UK and Dr. Raquel Franco Leal, University of Campinas, Brazil. The main purposes of this series are 1) to shed light onto potential links between epigenetic mechanisms and inflammatory bowel diseases (IBD) and to highlight new findings in this respect, 2) to explore progress in this field in pre-clinical models and in patients, and 3) to examine the role of environment in its broadest sense in IBD.
Evidence of epigenetics in inflammatory bowel diseases
A promising DNA methylation analysis pipeline for epigenetic studies and clinical implementation in inflammatory bowel disease
Histone acylations as a mechanism for regulation of intestinal epithelial cells
The exposome-diet-epigenome axis in inflammatory bowel diseases—a narrative review
Role of epigenetic mechanisms in inflammatory bowel disease
Ambient air pollution and inflammatory bowel disease—a narrative review
Disclosure:
The series on "Evidence of Epigenetics in Inflammatory Bowel Diseases" is commissioned by the editorial office, Digestive Medicine Research (DMR) without any sponsorship or funding Dr. Patrick Varga-Weisz and Dr. Raquel Franco Leal serve as the unpaid Guest Editors for the series.